UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 2829, 2026

Core Scientific, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-40046

86-1243837

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)


838 Walker Road, Suite 21-2105 Dover, Delaware						19904
(Address of principal executive offices)						(Zip Code)

Registrant’s telephone number, including area code: (512) 402-5233

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.00001 per share	CORZ	The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $6.81 per share	CORZW	The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $0.01 per share	CORZZ	The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 25.02 ~~Results~~Departure of ~~Operations~~Directors ~~and~~or ~~Financial~~Certain ~~Condition~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 28 29, 2026, the Company ~~issued~~announced the appointment of Mark W. Adams, as a ~~press~~member ~~release~~of ~~announcing~~the ~~its~~Board ~~financial~~of ~~results~~Directors, ~~for~~effective immediately. Mr. Adams, age 62, was President, Chief Executive Officer and a member of the ~~second~~Board ~~fiscal~~of ~~quarter~~Penguin ~~ended~~Solutions, ~~June~~ Inc., a leading provider of memory and AI infrastructure, from August 2020 to January 30, 2026. AFrom ~~copy~~February 2017 until March 2019, Mr. Adams was Chief Executive Officer of ~~the~~Lumileds, ~~press~~Inc., ~~release~~a isglobal ~~furnished~~leader ~~hereto~~in led lighting and OEM lighting solutions. Prior to that, Mr. Adams served as ~~Exhibit~~President 99of Micron Technology (“Micron”) from 2012 to 2016 and in various other leadership roles in Micron from 2006 to February 2012.1 Mr. Adams has over 25 years of experience in the technology sector, including semiconductors and memory solutions. Mr. Adams is ~~incorporated~~a ~~herein~~member byof ~~reference~~the Board of Seagate Technology Holdings Public Limited Company and Cadence Design Systems, Inc.

~~Item~~The 7Board after review of all relevant facts and circumstances has determined that Mr.~~01 Regulation~~ FDAdams ~~Disclosure~~is “independent” pursuant to the independence requirements of the Sarbanes-Oxley Act of 2002, as amended, and the applicable listing standards of the Nasdaq Stock Market, LLC.

~~The~~Mr. ~~information~~Adams ~~contained~~will inreceive ~~Item~~cash ~~2.02~~and isequity ~~incorporated~~compensation ~~herein~~for byBoard ~~reference~~service commensurate with the Company’s other non-employee directors.

The ~~information~~selection inof ~~Items 2~~Mr.02 ~~and~~Adams ~~7.01~~to ofserve ~~this~~as ~~Current~~a ~~Report~~member onof ~~Form~~the ~~8-K,~~Board ~~including~~was ~~Exhibit 99.1, is furnished and shall~~ not bepursuant ~~deemed~~to ~~“filed”~~any ~~for~~arrangement ~~purposes~~or ofunderstanding ~~Section~~with 18respect ofto ~~the~~any ~~Securities~~other ~~Exchange~~person. ~~Act~~There ofare ~~1934,~~no asfamily ~~amended,~~relationships ~~nor~~between ~~shall~~Mr. itAdams beand ~~deemed~~any ~~incorporated~~director byor ~~reference~~executive inofficer ~~any~~of ~~filing made by~~ the Company, ~~under~~and ~~the~~Mr. ~~Securities~~Adams ~~Act~~has ofno ~~1933,~~direct asor ~~amended,~~indirect ~~whether~~material ~~made~~interest ~~before~~in orany ~~after~~“related ~~the~~party” ~~date~~transaction ~~hereof,~~required ~~regardless~~to ofbe ~~any~~disclosed ~~general~~pursuant ~~incorporation~~to ~~language~~Item in404(a) ~~such~~of ~~filing~~Regulation S-K.

Item 7.01 Regulation FD Disclosure.

On July 29, 2026, the Company issued a press release announcing the appointment of Mark W. Adams to the Company’s Board of Directors described in Item 5.02 of this Current Report on Form 8-K. A copy of the press release is furnished as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statement and Exhibits

(d) Exhibits:

ExhibitNo.						Description
99.1						Press Release, dated July 2829, 2026
99.2						Company Presentation dated July 28, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Core Scientific, Inc.
Dated: July 28, 2026
Dated: July 29, 2026
	By:	/s/ Todd M. DuChene
	Name:	Todd M. DuChene
	Title:	Chief Legal Officer and Chief Administrative Officer

Filing Compare · Core Scientific, Inc./tx